RE:THIS IS A PRICE MOVER NEWSArchiePete wrote: PBI-4050 actually improves FVC ( as reported with Walkingred's uncle ).
This means that it is actually improving lung functions while both medications approved only slow its degradation.
Thus PBI-4050 is better then Perfinidone or nintedanib, so logically it is worth more then the 8.3 B$ one of the latter was sold for.
If this does not move the price, nothing will.
Logically we should more then double today....
What a week...
Pete
I believe the FVC is the biomarker that I was told about, that I was trying to explain here. (The drop in % that I was referering to as covereage)